{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:40:27Z","timestamp":1791488427211,"version":"4.3.4"},"publisher-location":"Cham","reference-count":139,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030829834","type":"print"},{"value":"9783030829841","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/164_2021_448","type":"book-chapter","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T12:03:52Z","timestamp":1614945832000},"page":"301-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Organic Cation Transporter (OCT\/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery"],"prefix":"10.1007","author":[{"given":"Robert D.","family":"Betterton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Ronaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,6]]},"reference":[{"issue":"4","key":"448_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1208\/s12248-017-0081-9","volume":"19","author":"W Abdullahi","year":"2017","unstructured":"Abdullahi W, Davis TP, Ronaldson PT (2017) Functional expression of P-glycoprotein and organic anion transporting polypeptides at the blood-brain barrier: understanding transport mechanisms for improved CNS drug delivery? AAPS J 19(4):931\u2013939. https:\/\/doi.org\/10.1208\/s12248-017-0081-9","journal-title":"AAPS J"},{"issue":"3","key":"448_CR2","doi-asserted-by":"publisher","first-page":"C343","DOI":"10.1152\/ajpcell.00095.2018","volume":"315","author":"W Abdullahi","year":"2018","unstructured":"Abdullahi W, Tripathi D, Ronaldson PT (2018) Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. Am J Physiol Cell Physiol 315(3):C343\u2013C356. https:\/\/doi.org\/10.1152\/ajpcell.00095.2018","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1\u20132","key":"448_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pain.2005.03.008","volume":"115","author":"AH Ahn","year":"2005","unstructured":"Ahn AH, Basbaum AI (2005) Where do triptans act in the treatment of migraine? Pain 115(1\u20132):1\u20134. https:\/\/doi.org\/10.1016\/j.pain.2005.03.008","journal-title":"Pain"},{"issue":"3","key":"448_CR4","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","volume":"16","author":"ZM Al-Majdoub","year":"2019","unstructured":"Al-Majdoub ZM, Al Feteisi H, Achour B et al (2019) Proteomic quantification of human blood\u2013brain barrier SLC and ABC transporters in healthy individuals and dementia patients. Mol Pharm 16(3):1220\u20131233. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b01189","journal-title":"Mol Pharm"},{"issue":"1","key":"448_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5853\/jos.2016.00864","volume":"19","author":"SJ An","year":"2017","unstructured":"An SJ, Kim TJ, Yoon B-W (2017) Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke 19(1):3\u201310. https:\/\/doi.org\/10.5853\/jos.2016.00864","journal-title":"J Stroke"},{"issue":"1","key":"448_CR6","doi-asserted-by":"publisher","first-page":"F165","DOI":"10.1152\/ajprenal.90257.2008","volume":"295","author":"M Aoki","year":"2008","unstructured":"Aoki M, Terada T, Kajiwara M et al (2008) Kidney-specific expression of human organic cation transporter 2 (OCT2\/SLC22A2) is regulated by DNA methylation. Am J Physiol Physiol 295(1):F165\u2013F170. https:\/\/doi.org\/10.1152\/ajprenal.90257.2008","journal-title":"Am J Physiol Physiol"},{"issue":"9","key":"448_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/mp.2011.87","volume":"17","author":"A Bacq","year":"2012","unstructured":"Bacq A, Balasse L, Biala G et al (2012) Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Mol Psychiatry 17(9):926\u2013939. https:\/\/doi.org\/10.1038\/mp.2011.87","journal-title":"Mol Psychiatry"},{"issue":"45","key":"448_CR8","doi-asserted-by":"publisher","first-page":"15185","DOI":"10.1523\/JNEUROSCI.2740-10.2010","volume":"30","author":"N Baganz","year":"2010","unstructured":"Baganz N, Horton R, Martin K, Holmes A, Daws LC (2010) Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J Neurosci 30(45):15185\u201315195. https:\/\/doi.org\/10.1523\/JNEUROSCI.2740-10.2010","journal-title":"J Neurosci"},{"key":"448_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fneur.2019.00218","volume":"10","author":"N Ball","year":"2019","unstructured":"Ball N, Teo W-P, Chandra S, Chapman J (2019) Parkinson\u2019s disease and the environment. Front Neurol 10:218. https:\/\/doi.org\/10.3389\/fneur.2019.00218","journal-title":"Front Neurol"},{"issue":"1","key":"448_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10048-010-0254-5","volume":"12","author":"ML Becker","year":"2011","unstructured":"Becker ML, Visser LE, van Schaik RHN, Hofman A, Uitterlinden AG, BHC S (2011) OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users. Neurogenetics 12(1):79\u201382. https:\/\/doi.org\/10.1007\/s10048-010-0254-5","journal-title":"Neurogenetics"},{"issue":"1","key":"448_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cpt.1373","volume":"106","author":"S Billington","year":"2019","unstructured":"Billington S, Salphati L, Hop CECA et al (2019) Interindividual and regional variability in drug transporter abundance at the human blood\u2013brain barrier measured by quantitative targeted proteomics. Clin Pharmacol Ther 106(1):228\u2013237. https:\/\/doi.org\/10.1002\/cpt.1373","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"448_CR12","doi-asserted-by":"publisher","first-page":"a005595","DOI":"10.1101\/cshperspect.a005595","volume":"4","author":"RD Blakely","year":"2012","unstructured":"Blakely RD, Edwards RH (2012) Vesicular and plasma membrane transporters for neurotransmitters. Cold Spring Harb Perspect Biol 4(2):a005595. https:\/\/doi.org\/10.1101\/cshperspect.a005595","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"448_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fpsyt.2014.00047","volume":"5","author":"R Brisch","year":"2014","unstructured":"Brisch R, Saniotis A, Wolf R et al (2014) The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psych 5:47. https:\/\/doi.org\/10.3389\/fpsyt.2014.00047","journal-title":"Front Psych"},{"issue":"1","key":"448_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000321965","volume":"65","author":"R Brouns","year":"2011","unstructured":"Brouns R, Wauters A, De Surgeloose D, Mari\u00ebn P, De Deyn PP (2011) Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. Eur Neurol 65(1):23\u201331. https:\/\/doi.org\/10.1159\/000321965","journal-title":"Eur Neurol"},{"key":"448_CR15","doi-asserted-by":"publisher","first-page":"117957351769380","DOI":"10.1177\/1179573517693802","volume":"9","author":"H Brzica","year":"2017","unstructured":"Brzica H, Abdullahi W, Ibbotson K, Ronaldson PT (2017) Role of transporters in central nervous system drug delivery and blood-brain barrier protection: relevance to treatment of stroke. J Cent Nerv Syst Dis 9:1179573517693802. https:\/\/doi.org\/10.1177\/1179573517693802","journal-title":"J Cent Nerv Syst Dis"},{"issue":"2","key":"448_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/mol.54.2.342","volume":"54","author":"AE Busch","year":"1998","unstructured":"Busch AE, Karbach U, Miska D et al (1998) Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 54(2):342\u2013352. https:\/\/doi.org\/10.1124\/mol.54.2.342","journal-title":"Mol Pharmacol"},{"issue":"10","key":"448_CR17","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.2174\/13816128113199990466","volume":"20","author":"C Chaves","year":"2014","unstructured":"Chaves C, Shawahna R, Jacob A (2014) Decl\u00e8ves* J-MS and X. Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration. Curr Pharm Des 20(10):1450\u20131462. https:\/\/doi.org\/10.2174\/13816128113199990466","journal-title":"Curr Pharm Des"},{"key":"448_CR18","doi-asserted-by":"publisher","unstructured":"Chaves C, Campanelli F, Chapy H et al (2020) An interspecies molecular and functional study of organic cation transporters at the blood-brain barrier: from rodents to humans. Pharmaceutics 12(4). https:\/\/doi.org\/10.3390\/pharmaceutics12040308","DOI":"10.3390\/pharmaceutics12040308"},{"issue":"11","key":"448_CR19","doi-asserted-by":"publisher","first-page":"6799","DOI":"10.1074\/jbc.M114.631556","volume":"290","author":"SJ Choi","year":"2015","unstructured":"Choi SJ, Panhelainen A, Schmitz Y et al (2015) Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure. J Biol Chem 290(11):6799\u20136809. https:\/\/doi.org\/10.1074\/jbc.M114.631556","journal-title":"J Biol Chem"},{"issue":"11","key":"448_CR20","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1124\/dmd.31.11.1337","volume":"31","author":"S Choudhuri","year":"2003","unstructured":"Choudhuri S, Cherrington NJ, Li N, Klaassen CD (2003) Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metab Dispos 31(11):1337\u20131345. https:\/\/doi.org\/10.1124\/dmd.31.11.1337","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"448_CR21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/jcp.20081","volume":"201","author":"G Ciarimboli","year":"2004","unstructured":"Ciarimboli G, Struwe K, Arndt P et al (2004) Regulation of the human organic cation transporter hOCT1. J Cell Physiol 201(3):420\u2013428. https:\/\/doi.org\/10.1002\/jcp.20081","journal-title":"J Cell Physiol"},{"issue":"8","key":"448_CR22","first-page":"504","volume":"40","author":"G DeMaagd","year":"2015","unstructured":"DeMaagd G, Philip A (2015) Parkinson\u2019s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P T 40(8):504\u2013532. https:\/\/pubmed.ncbi.nlm.nih.gov\/26236139","journal-title":"P T"},{"issue":"7","key":"448_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","volume":"40","author":"CL DeVane","year":"2001","unstructured":"DeVane CL, Nemeroff CB (2001) Clinical pharmacokinetics of quetiapine. Clin Pharmacokinet 40(7):509\u2013522. https:\/\/doi.org\/10.2165\/00003088-200140070-00003","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"448_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.bcp.2011.12.032","volume":"83","author":"D Dickens","year":"2012","unstructured":"Dickens D, Owen A, Alfirevic A et al (2012) Lamotrigine is a substrate for OCT1 in brain endothelial cells. Biochem Pharmacol 83(6):805\u2013814. https:\/\/doi.org\/10.1016\/j.bcp.2011.12.032","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"448_CR25","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1021\/acs.molpharmaceut.8b00547","volume":"15","author":"D Dickens","year":"2018","unstructured":"Dickens D, R\u00e4disch S, Chiduza GN et al (2018) Cellular uptake of the atypical antipsychotic clozapine is a carrier-mediated process. Mol Pharm 15(8):3557\u20133572. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00547","journal-title":"Mol Pharm"},{"issue":"1","key":"448_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-clinpsy-050817-084934","volume":"14","author":"LB Dixon","year":"2018","unstructured":"Dixon LB, Goldman HH, Srihari VH, Kane JM (2018) Transforming the treatment of schizophrenia in the United States: the RAISE initiative. Annu Rev Clin Psychol 14(1):237\u2013258. https:\/\/doi.org\/10.1146\/annurev-clinpsy-050817-084934","journal-title":"Annu Rev Clin Psychol"},{"issue":"6","key":"448_CR28","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1208\/s12248-014-9649-9","volume":"16","author":"JN Dos Santos Pereira","year":"2014","unstructured":"Dos Santos Pereira JN, Tadjerpisheh S, Abu Abed M et al (2014) The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family. AAPS J 16(6):1247\u20131258. https:\/\/doi.org\/10.1208\/s12248-014-9649-9","journal-title":"AAPS J"},{"issue":"3","key":"448_CR29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1124\/jpet.110.170142","volume":"335","author":"H Duan","year":"2010","unstructured":"Duan H, Wang J (2010) Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther 335(3):743\u2013753. https:\/\/doi.org\/10.1124\/jpet.110.170142","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"448_CR30","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1074\/jbc.M112.436972","volume":"288","author":"H Duan","year":"2013","unstructured":"Duan H, Wang J (2013) Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene. J Biol Chem 288(5):3535\u20133544. https:\/\/doi.org\/10.1074\/jbc.M112.436972","journal-title":"J Biol Chem"},{"issue":"48","key":"448_CR31","doi-asserted-by":"publisher","first-page":"50042","DOI":"10.1074\/jbc.M407913200","volume":"279","author":"K Engel","year":"2004","unstructured":"Engel K, Zhou M, Wang J (2004) Identification and characterization of a novel monoamine transporter in human brain. J Biol Chem 279(48):50042\u201350049. https:\/\/doi.org\/10.1074\/jbc.M407913200","journal-title":"J Biol Chem"},{"issue":"5","key":"448_CR32","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3390\/ijms21051791","volume":"21","author":"DC Engelhart","year":"2020","unstructured":"Engelhart DC, Granados JC, Shi D et al (2020) Systems biology analysis reveals eight SLC22 transporter subgroups, including OATs, OCTs, and OCTNs. Int J Mol Sci 21(5):1791. https:\/\/doi.org\/10.3390\/ijms21051791","journal-title":"Int J Mol Sci"},{"key":"448_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fncel.2018.00309","volume":"12","author":"Y Fan","year":"2018","unstructured":"Fan Y, Chen Z, Pathak JL, Carneiro AMD, Chung CY (2018) Differential regulation of adhesion and phagocytosis of resting and activated microglia by dopamine. Front Cell Neurosci 12:309. https:\/\/doi.org\/10.3389\/fncel.2018.00309","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"448_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0006-8993(02)04271-3","volume":"968","author":"A Friedrich","year":"2003","unstructured":"Friedrich A, Prasad PD, Freyer D, Ganapathy V, Brust P (2003) Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier. Brain Res 968(1):69\u201379. https:\/\/doi.org\/10.1016\/s0006-8993(02)04271-3","journal-title":"Brain Res"},{"issue":"8","key":"448_CR36","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1248\/bpb.b17-00076","volume":"40","author":"T Furihata","year":"2017","unstructured":"Furihata T, Anzai N (2017) Functional expression of organic ion transporters in astrocytes and their potential as a drug target in the treatment of central nervous system diseases. Biol Pharm Bull 40(8):1153\u20131160. https:\/\/doi.org\/10.1248\/bpb.b17-00076","journal-title":"Biol Pharm Bull"},{"issue":"12","key":"448_CR37","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j\/euroneuro.2019.10.013","volume":"29","author":"A Garcia-Bea","year":"2019","unstructured":"Garcia-Bea A, Miranda-Azpiazu P, Muguruza C et al (2019) Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: selective biased agonism via G\u03b1i1-proteins. Eur Neuropsychopharmacol 29(12):1453\u20131463. https:\/\/doi.org\/10.1016\/j\/euroneuro.2019.10.013","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"448_CR38","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.4049\/jimmunol.1400918","volume":"193","author":"L Garcia-Bonilla","year":"2014","unstructured":"Garcia-Bonilla L, Moore JM, Racchumi G et al (2014) Inducible nitric oxide synthase in neutrophils and endothelium contributes to ischemic brain injury in mice. J Immunol 193(5):2531\u20132537. https:\/\/doi.org\/10.4049\/jimmunol.1400918","journal-title":"J Immunol"},{"issue":"4","key":"448_CR39","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00429-016-1315-9","volume":"222","author":"PJ Gasser","year":"2017","unstructured":"Gasser PJ, Hurley MM, Chan J, Pickel VM (2017) Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice. Brain Struct Funct 222(4):1913\u20131928. https:\/\/doi.org\/10.1007\/s00429-016-1315-9","journal-title":"Brain Struct Funct"},{"issue":"6","key":"448_CR40","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/clpt.2013.175","volume":"94","author":"EG Geier","year":"2013","unstructured":"Geier EG, Chen EC, Webb A et al (2013) Profiling solute carrier transporters in the human blood\u2013brain barrier. Clin Pharmacol Ther 94(6):636\u2013639. https:\/\/doi.org\/10.1038\/clpt.2013.175","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"448_CR41","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/jon.12225","volume":"25","author":"M Giraud","year":"2015","unstructured":"Giraud M, Cho T-H, Nighoghossian N et al (2015) Early blood brain barrier changes in acute ischemic stroke: a sequential MRI study. J Neuroimaging 25(6):959\u2013963. https:\/\/doi.org\/10.1111\/jon.12225","journal-title":"J Neuroimaging"},{"issue":"3","key":"448_CR42","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1124\/jpet.102.038885","volume":"303","author":"KB Goralski","year":"2002","unstructured":"Goralski KB, Lou G, Prowse MT et al (2002) The cation transporters rOCT1 and rOCT2 interact with bicarbonate but play only a minor role for amantadine uptake into rat renal proximal tubules. J Pharmacol Exp Ther 303(3):959\u2013968. https:\/\/doi.org\/10.1124\/jpet.102.038885","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"448_CR43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1474-4422(19)30030-4","volume":"18","author":"PB Gorelick","year":"2019","unstructured":"Gorelick PB (2019) The global burden of stroke: persistent and disabling. Lancet Neurol 18(5):417\u2013418. https:\/\/doi.org\/10.1016\/S1474-4422(19)30030-4","journal-title":"Lancet Neurol"},{"issue":"6506","key":"448_CR44","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/372549a0","volume":"372","author":"D Gr\u00fcndemann","year":"1994","unstructured":"Gr\u00fcndemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372(6506):549\u2013552. https:\/\/doi.org\/10.1038\/372549a0","journal-title":"Nature"},{"issue":"47","key":"448_CR45","doi-asserted-by":"publisher","first-page":"30915","DOI":"10.1074\/jbc.273.47.30915","volume":"273","author":"D Gr\u00fcndemann","year":"1998","unstructured":"Gr\u00fcndemann D, K\u00f6ster S, Kiefer N et al (1998) Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J Biol Chem 273(47):30915\u201330920. https:\/\/doi.org\/10.1074\/jbc.273.47.30915","journal-title":"J Biol Chem"},{"issue":"14","key":"448_CR46","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1073\/pnas.0408624102","volume":"102","author":"D Gr\u00fcndemann","year":"2005","unstructured":"Gr\u00fcndemann D, Harlfinger S, Golz S et al (2005) Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A 102(14):5256\u20135261. https:\/\/doi.org\/10.1073\/pnas.0408624102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"448_CR47","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00210-012-0781-8","volume":"385","author":"B Haenisch","year":"2012","unstructured":"Haenisch B, Drescher E, Thiemer L et al (2012) Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3. Naunyn Schmiedebergs Arch Pharmacol 385(10):1017\u20131023. https:\/\/doi.org\/10.1007\/s00210-012-0781-8","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"448_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/1872312813666181129101507","volume":"13","author":"LW Han","year":"2019","unstructured":"Han LW, Gao C, Zhang Y, Wang J, Mao Q (2019) Transport of bupropion and its metabolites by the model CHO and HEK293 cell lines. Drug Metab Lett 13(1):25\u201336. https:\/\/doi.org\/10.2174\/1872312813666181129101507","journal-title":"Drug Metab Lett"},{"issue":"18","key":"448_CR49","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1021\/jm400966v","volume":"56","author":"R Hendrickx","year":"2013","unstructured":"Hendrickx R, Johansson JG, Lohmann C et al (2013) Identification of novel substrates and structure\u2013activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem 56(18):7232\u20137242. https:\/\/doi.org\/10.1021\/jm400966v","journal-title":"J Med Chem"},{"issue":"1","key":"448_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.freeradbiomed.2005.03.035","volume":"39","author":"JH Heo","year":"2005","unstructured":"Heo JH, Han SW, Lee SK (2005) Free radicals as triggers of brain edema formation after stroke. Free Radic Biol Med 39(1):51\u201370. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.03.035","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"448_CR51","doi-asserted-by":"publisher","first-page":"C678","DOI":"10.1152\/ajpcell.00090.2006","volume":"291","author":"M Hiasa","year":"2006","unstructured":"Hiasa M, Matsumoto T, Komatsu T, Moriyama Y (2006) Wide variety of locations for rodent MATE1, a transporter protein that mediates the final excretion step for toxic organic cations. Am J Physiol Physiol 291(4):C678\u2013C686. https:\/\/doi.org\/10.1152\/ajpcell.00090.2006","journal-title":"Am J Physiol Physiol"},{"issue":"2","key":"448_CR52","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.dmpk.2014.12.006","volume":"30","author":"K Higuchi","year":"2015","unstructured":"Higuchi K, Kitamura A, Okura T, Deguchi Y (2015) Memantine transport by a proton-coupled organic cation antiporter in hCMEC\/D3 cells, an in vitro human blood-brain barrier model. Drug Metab Pharmacokinet 30(2):182\u2013187. https:\/\/doi.org\/10.1016\/j.dmpk.2014.12.006","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"448_CR54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1124\/jpet.119.260877","volume":"372","author":"S H\u00f6rmann","year":"2020","unstructured":"H\u00f6rmann S, Gai Z, Kullak-Ublick GA, Visentin M (2020) Plasma membrane cholesterol regulates the allosteric binding of 1-methyl-4-phenylpyridinium to organic cation transporter 2 (SLC22A2). J Pharmacol Exp Ther 372(1):46\u201353. https:\/\/doi.org\/10.1124\/jpet.119.260877","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"448_CR55","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s10157-011-0460-y","volume":"15","author":"K Hosoya","year":"2011","unstructured":"Hosoya K, Tachikawa M (2011) Roles of organic anion\/cation transporters at the blood\u2013brain and blood\u2013cerebrospinal fluid barriers involving uremic toxins. Clin Exp Nephrol 15(4):478\u2013485. https:\/\/doi.org\/10.1007\/s10157-011-0460-y","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"448_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","volume":"96","author":"C Iadecola","year":"2017","unstructured":"Iadecola C (2017) The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron 96(1):17\u201342. https:\/\/doi.org\/10.1016\/j.neuron.2017.07.030","journal-title":"Neuron"},{"issue":"8","key":"448_CR57","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/bdd.371","volume":"24","author":"A Inano","year":"2003","unstructured":"Inano A, Sai Y, Nikaido H et al (2003) Acetyl-L-carnitine permeability across the blood\u2013brain barrier and involvement of carnitine transporter OCTN2. Biopharm Drug Dispos 24(8):357\u2013365. https:\/\/doi.org\/10.1002\/bdd.371","journal-title":"Biopharm Drug Dispos"},{"issue":"4","key":"448_CR58","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1124\/dmd.104.002519","volume":"33","author":"N Ishiguro","year":"2005","unstructured":"Ishiguro N, Saito A, Yokoyama K, Morikawa M, Igarashi T, Tamai I (2005) Transport of the dopamine D2; agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney. Drug Metab Dispos 33(4):495\u2013499. https:\/\/doi.org\/10.1124\/dmd.104.002519","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"448_CR59","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11064-017-2350-5","volume":"43","author":"T Ishimoto","year":"2018","unstructured":"Ishimoto T, Nakamichi N, Nishijima H, Masuo Y, Kato Y (2018) Carnitine\/organic cation transporter OCTN1 negatively regulates activation in murine cultured microglial cells. Neurochem Res 43(1):116\u2013128. https:\/\/doi.org\/10.1007\/s11064-017-2350-5","journal-title":"Neurochem Res"},{"issue":"5","key":"448_CR60","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s11064-010-0131-5","volume":"35","author":"E Januszewicz","year":"2010","unstructured":"Januszewicz E, Bekisz M, Mozrzymas JW, Na\u0142\u0119cz KA (2010) High affinity carnitine transporters from OCTN family in neural cells. Neurochem Res 35(5):743\u2013748. https:\/\/doi.org\/10.1007\/s11064-010-0131-5","journal-title":"Neurochem Res"},{"issue":"15","key":"448_CR61","doi-asserted-by":"publisher","first-page":"6496","DOI":"10.1128\/MCB.25.15.6496-6508.2005","volume":"25","author":"W Jiang","year":"2005","unstructured":"Jiang W, Prokopenko O, Wong L, Inouye M, Mirochnitchenko O (2005) IRIP, a new ischemia\/reperfusion-inducible protein that participates in the regulation of transporter activity. Mol Cell Biol 25(15):6496\u20136508. https:\/\/doi.org\/10.1128\/MCB.25.15.6496-6508.2005","journal-title":"Mol Cell Biol"},{"issue":"6","key":"448_CR62","doi-asserted-by":"publisher","first-page":"G1211","DOI":"10.1152\/ajpgi.90360.2008","volume":"295","author":"M Kajiwara","year":"2008","unstructured":"Kajiwara M, Terada T, Asaka J et al (2008) Regulation of basal core promoter activity of human organic cation transporter 1 (OCT1\/SLC22A1). Am J Physiol Liver Physiol 295(6):G1211\u2013G1216. https:\/\/doi.org\/10.1152\/ajpgi.90360.2008","journal-title":"Am J Physiol Liver Physiol"},{"issue":"5","key":"448_CR63","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1046\/j.1471-4159.2001.00621.x","volume":"79","author":"Y Kido","year":"2001","unstructured":"Kido Y, Tamai I, Ohnari A et al (2001) Functional relevance of carnitine transporter OCTN2 to brain distribution of l-carnitine and acetyl-l-carnitine across the blood\u2013brain barrier. J Neurochem 79(5):959\u2013969. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00621.x","journal-title":"J Neurochem"},{"issue":"1","key":"448_CR64","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1124\/pr.118.015578","volume":"72","author":"H Koepsell","year":"2020","unstructured":"Koepsell H (2020) Organic cation transporters in health and disease. Pharmacol Rev 72(1):253\u2013319. https:\/\/doi.org\/10.1124\/pr.118.015578","journal-title":"Pharmacol Rev"},{"key":"448_CR65","doi-asserted-by":"publisher","unstructured":"Koh SS, Ooi SC-Y, Lui NM-Y et al (2020) Effect of ergothioneine on 7-ketocholesterol-induced endothelial injury. Neuromolecular Med. https:\/\/doi.org\/10.1007\/s12017-020-08620-4","DOI":"10.1007\/s12017-020-08620-4"},{"key":"448_CR66","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1749-6632.1992.tb24527.x","volume":"648","author":"IJ Kopin","year":"1992","unstructured":"Kopin IJ (1992) Features of the dopaminergic neurotoxin MPTP. Ann N Y Acad Sci 648:96\u2013104. https:\/\/doi.org\/10.1111\/j.1749-6632.1992.tb24527.x","journal-title":"Ann N Y Acad Sci"},{"issue":"Pt 1","key":"448_CR67","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1113\/jphysiol.2002.021170","volume":"543","author":"D Kristufek","year":"2002","unstructured":"Kristufek D, Rudorfer W, Pifl C, Huck S (2002) Organic cation transporter mRNA and function in the rat superior cervical ganglion. J Physiol 543(Pt 1):117\u2013134. https:\/\/doi.org\/10.1113\/jphysiol.2002.021170","journal-title":"J Physiol"},{"issue":"12","key":"448_CR68","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1021\/acs.molpharmaceut.8b00697","volume":"15","author":"T Kurosawa","year":"2018","unstructured":"Kurosawa T, Tega Y, Higuchi K et al (2018) Expression and functional characterization of drug transporters in brain microvascular endothelial cells derived from human induced pluripotent stem cells. Mol Pharm 15(12):5546\u20135555. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00697","journal-title":"Mol Pharm"},{"issue":"s1","key":"448_CR69","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3233\/JPD-179006","volume":"7","author":"JW Langston","year":"2017","unstructured":"Langston JW (2017) The MPTP story. J Parkinsons Dis 7(s1):S11\u2013S19. https:\/\/doi.org\/10.3233\/JPD-179006","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"448_CR70","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jhep.2017.11.026","volume":"68","author":"HH Lau","year":"2018","unstructured":"Lau HH, Ng NHJ, Loo LSW, Jasmen JB, Teo AKK (2018) The molecular functions of hepatocyte nuclear factors - in and beyond the liver. J Hepatol 68(5):1033\u20131048. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.026","journal-title":"J Hepatol"},{"issue":"7","key":"448_CR71","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1021\/mp400013t","volume":"10","author":"Q Li","year":"2013","unstructured":"Li Q, Yang H, Peng X et al (2013) Ischemia\/reperfusion-inducible protein modulates the function of organic cation transporter 1 and multidrug and toxin extrusion 1. Mol Pharm 10(7):2578\u20132587. https:\/\/doi.org\/10.1021\/mp400013t","journal-title":"Mol Pharm"},{"issue":"9","key":"448_CR73","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/bdd.2104","volume":"38","author":"L Li","year":"2017","unstructured":"Li L, Weng Y, Wang W et al (2017) Multiple organic cation transporters contribute to the renal transport of sulpiride. Biopharm Drug Dispos 38(9):526\u2013534. https:\/\/doi.org\/10.1002\/bdd.2104","journal-title":"Biopharm Drug Dispos"},{"key":"448_CR74","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fphar.2020.00064","volume":"11","author":"L Li","year":"2020","unstructured":"Li L, Sun L, Qiu Y, Zhu W, Hu K, Mao J (2020) Protective effect of Stachydrine against cerebral ischemia-reperfusion injury by reducing inflammation and apoptosis through P65 and JAK2\/STAT3 signaling pathway. Front Pharmacol 11:64. https:\/\/doi.org\/10.3389\/fphar.2020.00064","journal-title":"Front Pharmacol"},{"key":"448_CR75","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fnins.2015.00032","volume":"9","author":"SA Liddelow","year":"2015","unstructured":"Liddelow SA (2015) Development of the choroid plexus and blood-CSF barrier. Front Neurosci 9:32. https:\/\/doi.org\/10.3389\/fnins.2015.00032","journal-title":"Front Neurosci"},{"issue":"3","key":"448_CR76","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1471-4159.2010.06801.x","volume":"114","author":"C-J Lin","year":"2010","unstructured":"Lin C-J, Tai Y, Huang M-T et al (2010) Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents. J Neurochem 114(3):717\u2013727. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06801.x","journal-title":"J Neurochem"},{"issue":"1","key":"448_CR77","doi-asserted-by":"publisher","first-page":"47","DOI":"10.6030\/1939-067x-3.1.47","volume":"3","author":"S Liu","year":"2010","unstructured":"Liu S, Levine SR, Winn HR (2010) Targeting ischemic penumbra: part I - from pathophysiology to therapeutic strategy. J Exp Stroke Transl Med 3(1):47\u201355. https:\/\/doi.org\/10.6030\/1939-067x-3.1.47","journal-title":"J Exp Stroke Transl Med"},{"issue":"9","key":"448_CR78","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/jcbfm.2010.29","volume":"30","author":"JJ Lochhead","year":"2010","unstructured":"Lochhead JJ, McCaffrey G, Quigley CE et al (2010) Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab 30(9):1625\u20131636. https:\/\/doi.org\/10.1038\/jcbfm.2010.29","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"448_CR79","doi-asserted-by":"publisher","first-page":"H582","DOI":"10.1152\/ajpheart.00889.2011","volume":"302","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, McCaffrey G, Sanchez-Covarrubias L et al (2012) Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain. Am J Physiol Heart Circ Physiol 302(3):H582\u2013H593. https:\/\/doi.org\/10.1152\/ajpheart.00889.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"448_CR80","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1208\/s12248-017-0076-6","volume":"19","author":"JJ Lochhead","year":"2017","unstructured":"Lochhead JJ, Ronaldson PT, Davis TP (2017) Hypoxic stress and inflammatory pain disrupt blood-brain barrier tight junctions: implications for drug delivery to the central nervous system. AAPS J 19(4):910\u2013920. https:\/\/doi.org\/10.1208\/s12248-017-0076-6","journal-title":"AAPS J"},{"key":"448_CR81","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3389\/fphys.2020.00914","volume":"11","author":"JJ Lochhead","year":"2020","unstructured":"Lochhead JJ, Yang J, Ronaldson PT, Davis TP (2020) Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders. Front Physiol 11:914. https:\/\/doi.org\/10.3389\/fphys.2020.00914","journal-title":"Front Physiol"},{"issue":"6","key":"448_CR82","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1248\/bpb.31.1230","volume":"31","author":"T Maeda","year":"2008","unstructured":"Maeda T, Wakasawa T, Funabashi M et al (2008) Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha. Biol Pharm Bull 31(6):1230\u20131236. https:\/\/doi.org\/10.1248\/bpb.31.1230","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"448_CR83","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/cpt.317","volume":"99","author":"J Matthaei","year":"2016","unstructured":"Matthaei J, Kuron D, Faltraco F et al (2016) OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics. Clin Pharmacol Ther 99(6):633\u2013641. https:\/\/doi.org\/10.1002\/cpt.317","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"448_CR84","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1471-4159.2009.06113.x","volume":"110","author":"G McCaffrey","year":"2009","unstructured":"McCaffrey G, Willis CL, Staatz WD et al (2009) Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. J Neurochem 110(1):58\u201371. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06113.x","journal-title":"J Neurochem"},{"issue":"12","key":"448_CR85","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1021\/mp400316e","volume":"10","author":"DC Mehta","year":"2013","unstructured":"Mehta DC, Short JL, Nicolazzo JA (2013) Memantine transport across the mouse blood\u2013brain barrier is mediated by a cationic influx H+ antiporter. Mol Pharm 10(12):4491\u20134498. https:\/\/doi.org\/10.1021\/mp400316e","journal-title":"Mol Pharm"},{"issue":"5","key":"448_CR87","doi-asserted-by":"publisher","first-page":"9949","DOI":"10.3390\/ijms16059949","volume":"16","author":"S Michinaga","year":"2015","unstructured":"Michinaga S, Koyama Y (2015) Pathogenesis of brain edema and investigation into anti-edema drugs. Int J Mol Sci 16(5):9949\u20139975. https:\/\/doi.org\/10.3390\/ijms16059949","journal-title":"Int J Mol Sci"},{"issue":"1","key":"448_CR88","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1471-4159.2007.05024.x","volume":"104","author":"D Miecz","year":"2008","unstructured":"Miecz D, Januszewicz E, Czeredys M et al (2008) Localization of organic cation\/carnitine transporter (OCTN2) in cells forming the blood\u2013brain barrier. J Neurochem 104(1):113\u2013123. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05024.x","journal-title":"J Neurochem"},{"key":"448_CR89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4137\/PMC.S13384","volume":"6","author":"JL Mikitsh","year":"2014","unstructured":"Mikitsh JL, Chacko A-M (2014) Pathways for small molecule delivery to the central nervous system across the blood-brain barrier. Perspect Med Chem 6:11\u201324. https:\/\/doi.org\/10.4137\/PMC.S13384","journal-title":"Perspect Med Chem"},{"issue":"4","key":"448_CR90","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1177\/0271678X16650216","volume":"37","author":"VR More","year":"2017","unstructured":"More VR, Campos CR, Evans RA et al (2017) PPAR-\u03b1, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression. J Cereb Blood Flow Metab 37(4):1199\u20131212. https:\/\/doi.org\/10.1177\/0271678X16650216","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"448_CR91","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","volume":"19","author":"ME Morris","year":"2017","unstructured":"Morris ME, Rodriguez-Cruz V, Felmlee MA (2017) SLC and ABC transporters: expression, localization, and species differences at the blood-brain and the blood-cerebrospinal fluid barriers. AAPS J 19(5):1317\u20131331. https:\/\/doi.org\/10.1208\/s12248-017-0110-8","journal-title":"AAPS J"},{"issue":"12","key":"448_CR92","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1503\/cmaj.140355","volume":"187","author":"TD Musuka","year":"2015","unstructured":"Musuka TD, Wilton SB, Traboulsi M, Hill MD (2015) Diagnosis and management of acute ischemic stroke: speed is critical. CMAJ 187(12):887\u2013893. https:\/\/doi.org\/10.1503\/cmaj.140355","journal-title":"CMAJ"},{"key":"448_CR93","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.brainres.2007.09.072","volume":"1184","author":"H Nakayama","year":"2007","unstructured":"Nakayama H, Kitaichi K, Ito Y et al (2007) The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats. Brain Res 1184:260\u2013269. https:\/\/doi.org\/10.1016\/j.brainres.2007.09.072","journal-title":"Brain Res"},{"key":"448_CR95","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1471-2199-10-68","volume":"10","author":"M Niehof","year":"2009","unstructured":"Niehof M, Borlak J (2009) Expression of HNF4alpha in the human and rat choroid plexus: implications for drug transport across the blood-cerebrospinal-fluid (CSF) barrier. BMC Mol Biol 10:68. https:\/\/doi.org\/10.1186\/1471-2199-10-68","journal-title":"BMC Mol Biol"},{"key":"448_CR96","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3389\/fnins.2016.00575","volume":"10","author":"H Nishijima","year":"2016","unstructured":"Nishijima H, Tomiyama M (2016) What mechanisms are responsible for the reuptake of levodopa-derived dopamine in parkinsonian striatum? Front Neurosci 10:575. https:\/\/doi.org\/10.3389\/fnins.2016.00575","journal-title":"Front Neurosci"},{"issue":"1","key":"448_CR98","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1124\/jpet.113.206359","volume":"347","author":"VP O\u2019Brien","year":"2013","unstructured":"O\u2019Brien VP, Bokelmann K, Ram\u00edrez J et al (2013) Hepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 gene. J Pharmacol Exp Ther 347(1):181\u2013192. https:\/\/doi.org\/10.1124\/jpet.113.206359","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"448_CR99","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1006\/bbrc.1996.1056","volume":"224","author":"M Okuda","year":"1996","unstructured":"Okuda M, Saito H, Urakami Y, Takano M, Inui K (1996) cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun 224(2):500\u2013507. https:\/\/doi.org\/10.1006\/bbrc.1996.1056","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"448_CR100","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2133\/dmpk.dmpk-13-rg-058","volume":"29","author":"T Okura","year":"2014","unstructured":"Okura T, Kato S, Deguchi Y (2014) Functional expression of organic cation\/carnitine transporter 2 (OCTN2\/SLC22A5) in human brain capillary endothelial cell line hCMEC\/D3, a human blood-brain barrier model. Drug Metab Pharmacokinet 29(1):69\u201374. https:\/\/doi.org\/10.2133\/dmpk.dmpk-13-rg-058","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"448_CR102","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ng1339","volume":"36","author":"VD Peltekova","year":"2004","unstructured":"Peltekova VD, Wintle RF, Rubin LA et al (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36(5):471\u2013475. https:\/\/doi.org\/10.1038\/ng1339","journal-title":"Nat Genet"},{"issue":"2","key":"448_CR104","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/2472555218812821","volume":"24","author":"L Pochini","year":"2019","unstructured":"Pochini L, Galluccio M, Scalise M, Console L, Indiveri C (2019) OCTN: a small transporter subfamily with great relevance to human pathophysiology, drug discovery, and diagnostics. SLAS Discov Adv Life Sci R D 24(2):89\u2013110. https:\/\/doi.org\/10.1177\/2472555218812821","journal-title":"SLAS Discov Adv Life Sci R D"},{"issue":"2","key":"448_CR105","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1124\/dmd.108.024646","volume":"37","author":"JW Polli","year":"2009","unstructured":"Polli JW, Olson KL, Chism JP et al (2009) An unexpected synergist role of p-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor Lapatinib. Drug Metab Dispos 37(2):439\u2013442. https:\/\/doi.org\/10.1124\/dmd.108.024646","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"448_CR106","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s12035-011-8214-0","volume":"44","author":"MV Puig","year":"2011","unstructured":"Puig MV, Gulledge AT (2011) Serotonin and prefrontal cortex function: neurons, networks, and circuits. Mol Neurobiol 44(3):449\u2013464. https:\/\/doi.org\/10.1007\/s12035-011-8214-0","journal-title":"Mol Neurobiol"},{"issue":"12","key":"448_CR108","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.3390\/ijms20123108","volume":"20","author":"AR Razzak","year":"2019","unstructured":"Razzak AR, Florence GJ (2019) Approaches to CNS drug delivery with a focus on transporter-mediated transcytosis. Int J Mol Sci 20(12):3108","journal-title":"Int J Mol Sci"},{"issue":"1","key":"448_CR109","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2045-8118-8-3","volume":"8","author":"Z Redzic","year":"2011","unstructured":"Redzic Z (2011) Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 8(1):3. https:\/\/doi.org\/10.1186\/2045-8118-8-3","journal-title":"Fluids Barriers CNS"},{"key":"448_CR110","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brainres.2015.03.018","volume":"1623","author":"PT Ronaldson","year":"2015","unstructured":"Ronaldson PT, Davis TP (2015) Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury. Brain Res 1623:39\u201352. https:\/\/doi.org\/10.1016\/j.brainres.2015.03.018","journal-title":"Brain Res"},{"issue":"5","key":"448_CR111","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/s1734-1140(13)71491-9","volume":"65","author":"A Rulcova","year":"2013","unstructured":"Rulcova A, Krausova L, Smutny T et al (2013) Glucocorticoid receptor regulates organic cation transporter 1 (OCT1, SLC22A1) expression via HNF4\u03b1 upregulation in primary human hepatocytes. Pharmacol Rep 65(5):1322\u20131335. https:\/\/doi.org\/10.1016\/s1734-1140(13)71491-9","journal-title":"Pharmacol Rep"},{"issue":"2","key":"448_CR112","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1124\/jpet.105.099929","volume":"317","author":"M Saborowski","year":"2006","unstructured":"Saborowski M, Kullak-Ublick GA, Eloranta JJ (2006) The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha. J Pharmacol Exp Ther 317(2):778\u2013785. https:\/\/doi.org\/10.1124\/jpet.105.099929","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"448_CR113","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","volume":"32","author":"KE Sandoval","year":"2008","unstructured":"Sandoval KE, Witt KA (2008) Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 32(2):200\u2013219. https:\/\/doi.org\/10.1016\/j.nbd.2008.08.005","journal-title":"Neurobiol Dis"},{"issue":"3","key":"448_CR114","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1124\/mol.117.111443","volume":"94","author":"PJ Sandoval","year":"2018","unstructured":"Sandoval PJ, Zorn KM, Clark AM, Ekins S, Wright SH (2018) Assessment of substrate-dependent ligand interactions at the organic cation transporter OCT2 using six model substrates. Mol Pharmacol 94(3):1057\u20131068. https:\/\/doi.org\/10.1124\/mol.117.111443","journal-title":"Mol Pharmacol"},{"issue":"3","key":"448_CR115","doi-asserted-by":"publisher","first-page":"e0173474","DOI":"10.1371\/journal.pone.0173474","volume":"12","author":"GN Sekhar","year":"2017","unstructured":"Sekhar GN, Georgian AR, Sanderson L et al (2017) Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB). PLoS One 12(3):e0173474. https:\/\/doi.org\/10.1371\/journal.pone.0173474","journal-title":"PLoS One"},{"issue":"1","key":"448_CR116","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12987-019-0158-1","volume":"16","author":"GN Sekhar","year":"2019","unstructured":"Sekhar GN, Fleckney AL, Boyanova ST et al (2019) Region-specific blood\u2013brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer\u2019s disease. Fluids Barriers CNS 16(1):38. https:\/\/doi.org\/10.1186\/s12987-019-0158-1","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"448_CR117","doi-asserted-by":"publisher","first-page":"10880","DOI":"10.1038\/ncomms10880","volume":"7","author":"JA Sprowl","year":"2016","unstructured":"Sprowl JA, Ong SS, Gibson AA et al (2016) A phosphotyrosine switch regulates organic cation transporters. Nat Commun 7(1):10880. https:\/\/doi.org\/10.1038\/ncomms10880","journal-title":"Nat Commun"},{"issue":"3","key":"448_CR118","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1017\/S1092852918001013","volume":"23","author":"S Stahl","year":"2018","unstructured":"Stahl S (2018) Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate. CNS Spectr 23(3):187\u2013191. https:\/\/doi.org\/10.1017\/S1092852918001013","journal-title":"CNS Spectr"},{"issue":"1","key":"448_CR119","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12987-018-0102-9","volume":"15","author":"EG Stopa","year":"2018","unstructured":"Stopa EG, Tanis KQ, Miller MC et al (2018) Comparative transcriptomics of choroid plexus in Alzheimer\u2019s disease, frontotemporal dementia and Huntington\u2019s disease: implications for CSF homeostasis. Fluids Barriers CNS 15(1):18. https:\/\/doi.org\/10.1186\/s12987-018-0102-9","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"448_CR120","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1124\/dmd.104.002220","volume":"33","author":"J-H Sung","year":"2005","unstructured":"Sung J-H, Yu K-H, Park J-S et al (2005) Saturable distribution of Tacrine into the striatal extracellular fluid of the rat: evidence of involvement of multiple organic cation transporters in the transport. Drug Metab Dispos 33(3):440\u2013448. https:\/\/doi.org\/10.1124\/dmd.104.002220","journal-title":"Drug Metab Dispos"},{"issue":"45","key":"448_CR121","doi-asserted-by":"publisher","first-page":"41611","DOI":"10.1074\/jbc.M108472200","volume":"276","author":"DH Sweet","year":"2001","unstructured":"Sweet DH, Miller DS, Pritchard JB (2001) Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus. J Biol Chem 276(45):41611\u201341619. https:\/\/doi.org\/10.1074\/jbc.M108472200","journal-title":"J Biol Chem"},{"issue":"5","key":"448_CR124","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1017\/S1461145705006103","volume":"9","author":"A Takano","year":"2006","unstructured":"Takano A, Suhara T, Yasuno F et al (2006) The antipsychotic sultopride is overdosed--a PET study of drug-induced receptor occupancy in comparison with sulpiride. Int J Neuropsychopharmacol 9(5):539\u2013545. https:\/\/doi.org\/10.1017\/S1461145705006103","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"448_CR125","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0014-5793(97)01441-5","volume":"419","author":"I Tamai","year":"1997","unstructured":"Tamai I, Yabuuchi H, Nezu J et al (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419(1):107\u2013111. https:\/\/doi.org\/10.1016\/s0014-5793(97)01441-5","journal-title":"FEBS Lett"},{"issue":"2","key":"448_CR126","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0005-2736(01)00328-5","volume":"1512","author":"I Tamai","year":"2001","unstructured":"Tamai I, China K, Sai Y et al (2001) Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochim Biophys Acta 1512(2):273\u2013284. https:\/\/doi.org\/10.1016\/s0005-2736(01)00328-5","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"448_CR127","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1021\/mp0340082","volume":"1","author":"I Tamai","year":"2004","unstructured":"Tamai I, Nakanishi T, Kobayashi D et al (2004) Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. Mol Pharm 1(1):57\u201366. https:\/\/doi.org\/10.1021\/mp0340082","journal-title":"Mol Pharm"},{"issue":"1","key":"448_CR128","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s41598-018-20021-z","volume":"8","author":"RMY Tang","year":"2018","unstructured":"Tang RMY, Cheah IK-M, Yew TSK, Halliwell B (2018) Distribution and accumulation of dietary ergothioneine and its metabolites in mouse tissues. Sci Rep 8(1):1601. https:\/\/doi.org\/10.1038\/s41598-018-20021-z","journal-title":"Sci Rep"},{"key":"448_CR129","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.apha.2014.06.013","volume":"71","author":"BJ Thompson","year":"2014","unstructured":"Thompson BJ, Ronaldson PT (2014) Drug delivery to the ischemic brain. Adv Pharmacol 71:165\u2013202. https:\/\/doi.org\/10.1016\/bs.apha.2014.06.013","journal-title":"Adv Pharmacol"},{"issue":"4","key":"448_CR130","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ng1267","volume":"35","author":"S Tokuhiro","year":"2003","unstructured":"Tokuhiro S, Yamada R, Chang X et al (2003) An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35(4):341\u2013348. https:\/\/doi.org\/10.1038\/ng1267","journal-title":"Nat Genet"},{"issue":"1","key":"448_CR131","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0378-4347(96)00428-8","volume":"691","author":"H Tokunaga","year":"1997","unstructured":"Tokunaga H, Kudo K, Jitsufuchi N, Ohtsuka Y, Imamura T (1997) Sensitive determination of sulpiride in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 691(1):203\u2013207. https:\/\/doi.org\/10.1016\/s0378-4347(96)00428-8","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"448_CR132","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnmol.2018.00010","volume":"11","author":"TJ Tracey","year":"2018","unstructured":"Tracey TJ, Steyn FJ, Wolvetang EJ, Ngo ST (2018) Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease. Front Mol Neurosci 11:10. https:\/\/doi.org\/10.3389\/fnmol.2018.00010","journal-title":"Front Mol Neurosci"},{"key":"448_CR133","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ics.2005.02.013","volume":"1277","author":"A Tsuji","year":"2005","unstructured":"Tsuji A (2005) Influx transporters and drug targeting: application of peptide and cation transporters. Int Congr Ser 1277:75\u201384. https:\/\/doi.org\/10.1016\/j.ics.2005.02.013","journal-title":"Int Congr Ser"},{"key":"448_CR134","doi-asserted-by":"publisher","unstructured":"Uchida Y, Goto R, Takeuchi H et al (2020) Abundant expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1 and xCT transporters in blood-arachnoid barrier of pig, and polarized localizations at CSF- and blood-facing plasma membranes. Drug Metab Dispos 48(2):135\u2013145.https:\/\/doi.org\/10.1124\/dmd.119.089516","DOI":"10.1124\/dmd.119.089516"},{"issue":"2","key":"448_CR135","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0014-5793(00)01525-8","volume":"473","author":"Y Urakami","year":"2000","unstructured":"Urakami Y, Okuda M, Saito H, Inui K (2000) Hormonal regulation of organic cation transporter OCT2 expression in rat kidney. FEBS Lett 473(2):173\u2013176. https:\/\/doi.org\/10.1016\/S0014-5793(00)01525-8","journal-title":"FEBS Lett"},{"issue":"1","key":"448_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bdd.693","volume":"31","author":"AL VanWert","year":"2010","unstructured":"VanWert AL, Gionfriddo MR, Sweet DH (2010) Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharm Drug Dispos 31(1):1\u201371. https:\/\/doi.org\/10.1002\/bdd.693","journal-title":"Biopharm Drug Dispos"},{"issue":"11","key":"448_CR137","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1523\/JNEUROSCI.5147-03.2004","volume":"24","author":"V Vialou","year":"2004","unstructured":"Vialou V, Amphoux A, Zwart R, Giros B, Gautron S (2004) Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci 24(11):2846\u20132851. https:\/\/doi.org\/10.1523\/JNEUROSCI.5147-03.2004","journal-title":"J Neurosci"},{"issue":"2","key":"448_CR138","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1124\/mol.109.054783","volume":"76","author":"C Volk","year":"2009","unstructured":"Volk C, Gorboulev V, Kotzsch A, M\u00fcller TD, Koepsell H (2009) Five amino acids in the innermost cavity of the substrate binding cleft of organic cation transporter 1 interact with extracellular and intracellular corticosterone. Mol Pharmacol 76(2):275\u2013289. https:\/\/doi.org\/10.1124\/mol.109.054783","journal-title":"Mol Pharmacol"},{"issue":"1","key":"448_CR139","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12035-012-8335-0","volume":"47","author":"J Wang","year":"2013","unstructured":"Wang J, Cheng H, Li X, Lu W, Wang K, Wen T (2013) Regulation of neural stem cell differentiation by transcription factors HNF4-1 and MAZ-1. Mol Neurobiol 47(1):228\u2013240. https:\/\/doi.org\/10.1007\/s12035-012-8335-0","journal-title":"Mol Neurobiol"},{"issue":"10","key":"448_CR140","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1248\/bpb.25.1345","volume":"25","author":"K Watanabe","year":"2002","unstructured":"Watanabe K, Sawano T, Endo T, Sakata M, Sato J (2002) Studies on intestinal absorption of Sulpiride (2): Transepithelial transport of Sulpiride across the human intestinal cell line Caco-2. Biol Pharm Bull 25(10):1345\u20131350. https:\/\/doi.org\/10.1248\/bpb.25.1345","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"448_CR142","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/pharmaceutics12020154","volume":"12","author":"EI Williams","year":"2020","unstructured":"Williams EI, Betterton RD, Davis TP, Ronaldson PT (2020) Transporter-mediated delivery of small molecule drugs to the brain: a critical mechanism that can advance therapeutic development for ischemic stroke. Pharmaceutics 12(2):154. https:\/\/doi.org\/10.3390\/pharmaceutics12020154","journal-title":"Pharmaceutics"},{"issue":"6","key":"448_CR143","doi-asserted-by":"publisher","first-page":"H2820","DOI":"10.1152\/ajpheart.00589.2003","volume":"285","author":"KA Witt","year":"2003","unstructured":"Witt KA, Mark KS, Hom S, Davis TP (2003) Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Circ Physiol 285(6):H2820\u2013H2831. https:\/\/doi.org\/10.1152\/ajpheart.00589.2003","journal-title":"Am J Physiol Circ Physiol"},{"issue":"1","key":"448_CR144","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mvr.2007.06.004","volume":"75","author":"KA Witt","year":"2008","unstructured":"Witt KA, Mark KS, Sandoval KE, Davis TP (2008) Reoxygenation stress on blood\u2013brain barrier paracellular permeability and edema in the rat. Microvasc Res 75(1):91\u201396. https:\/\/doi.org\/10.1016\/j.mvr.2007.06.004","journal-title":"Microvasc Res"},{"key":"448_CR145","doi-asserted-by":"crossref","unstructured":"Wong YWJ, Yeh C, Thyrum PT (2001) The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine. J Clin Psychopharmacol 21(1). https:\/\/journals.lww.com\/psychopharmacology\/Fulltext\/2001\/02000\/The_Effects_of_Concomitant_Phenytoin.16.aspx","DOI":"10.1097\/00004714-200102000-00016"},{"issue":"3","key":"448_CR146","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1006\/bbrc.1998.8669","volume":"246","author":"X Wu","year":"1998","unstructured":"Wu X, Prasad PD, Leibach FH, Ganapathy V (1998) cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246(3):589\u2013595. https:\/\/doi.org\/10.1006\/bbrc.1998.8669","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"448_CR147","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/jcbfm.2014.162","volume":"35","author":"K-C Wu","year":"2015","unstructured":"Wu K-C, Lu Y-H, Peng Y-H et al (2015) Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice. J Cereb Blood Flow Metab 35(1):37\u201347. https:\/\/doi.org\/10.1038\/jcbfm.2014.162","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"448_CR148","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/1471-2164-12-499","volume":"12","author":"H Xu","year":"2011","unstructured":"Xu H, Lu A, Sharp FR (2011) Regional genome transcriptional response of adult mouse brain to hypoxia. BMC Genomics 12(1):499. https:\/\/doi.org\/10.1186\/1471-2164-12-499","journal-title":"BMC Genomics"},{"issue":"4","key":"448_CR149","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/pharmaceutics10040192","volume":"10","author":"J Yang","year":"2018","unstructured":"Yang J, Reilly BG, Davis TP, Ronaldson PT (2018) Modulation of opioid transport at the blood-brain barrier by altered ATP-binding cassette (ABC) transporter expression and activity. Pharmaceutics 10(4):192. https:\/\/doi.org\/10.3390\/pharmaceutics10040192","journal-title":"Pharmaceutics"},{"issue":"6","key":"448_CR150","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/glia.22484","volume":"61","author":"T Yoshikawa","year":"2013","unstructured":"Yoshikawa T, Naganuma F, Iida T et al (2013) Molecular mechanism of histamine clearance by primary human astrocytes. Glia 61(6):905\u2013916. https:\/\/doi.org\/10.1002\/glia.22484","journal-title":"Glia"},{"issue":"12","key":"448_CR151","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s00210-020-01868-4","volume":"393","author":"L Zhang","year":"2020","unstructured":"Zhang L, Li F, Hou C et al (2020) Design, synthesis, and biological evaluation of novel stachydrine derivatives as potent neuroprotective agents for cerebral ischemic stroke. Naunyn Schmiedebergs Arch Pharmacol 393(12):2529\u20132542. https:\/\/doi.org\/10.1007\/s00210-020-01868-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"11","key":"448_CR152","doi-asserted-by":"publisher","first-page":"e0140569","DOI":"10.1371\/journal.pone.0140569.","volume":"10","author":"C Zhu","year":"2015","unstructured":"Zhu C, Nigam KB, Date RC et al (2015) Evolutionary analysis and classification of OATs, OCTs, OCTNs, and other SLC22 transporters: structure-function implications and analysis of sequence motifs. PLoS One 10(11):e0140569. https:\/\/doi.org\/10.1371\/journal.pone.0140569.","journal-title":"PLoS One"}],"container-title":["Handbook of Experimental Pharmacology","Organic Cation Transporters in the Central Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2021_448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T19:34:41Z","timestamp":1635276881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2021_448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030829834","9783030829841"],"references-count":139,"URL":"https:\/\/doi.org\/10.1007\/164_2021_448","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"6 March 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}